Cargando…
Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial
OBJECTIVES: Sporadic Inclusion Body Myositis (IBM) is an inflammatory muscle disease affecting individuals over the age of 45, leading to progressive muscle wasting, disability and loss of independence. Histologically, IBM is characterised by immune changes including myofibres expressing major histo...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495304/ https://www.ncbi.nlm.nih.gov/pubmed/36188123 http://dx.doi.org/10.1002/cti2.1416 |
_version_ | 1784793984768409600 |
---|---|
author | Coudert, Jerome D Slater, Nataliya Sooda, Anuradha Beer, Kelly Lim, Ee Mun Boyder, Conchita Zhang, Rui Mastaglia, Frank L Learmonth, Yvonne C Fairchild, Timothy J Yeap, Bu B Needham, Merrilee |
author_facet | Coudert, Jerome D Slater, Nataliya Sooda, Anuradha Beer, Kelly Lim, Ee Mun Boyder, Conchita Zhang, Rui Mastaglia, Frank L Learmonth, Yvonne C Fairchild, Timothy J Yeap, Bu B Needham, Merrilee |
author_sort | Coudert, Jerome D |
collection | PubMed |
description | OBJECTIVES: Sporadic Inclusion Body Myositis (IBM) is an inflammatory muscle disease affecting individuals over the age of 45, leading to progressive muscle wasting, disability and loss of independence. Histologically, IBM is characterised by immune changes including myofibres expressing major histocompatibility complex molecules and invaded by CD8(+) T cells and macrophages, and by degenerative changes including protein aggregates organised in inclusion bodies, rimmed vacuoles and mitochondrial abnormalities. There is currently no cure, and regular exercise is currently the only recognised treatment effective at limiting muscle weakening, atrophy and loss of function. Testosterone exerts anti‐inflammatory effects, inhibiting effector T‐cell differentiation and pro‐inflammatory cytokine production. METHODS: We conducted a double‐blind, placebo‐controlled, cross‐over trial in men with IBM, to assess whether a personalised progressive exercise training combined with application of testosterone, reduced the inflammatory immune response associated with this disease over and above exercise alone. To assess intervention efficacy, we immunophenotyped blood immune cells by flow cytometry, and measured serum cytokines and chemokines by Luminex immunoassay. RESULTS: Testosterone supplementation resulted in modest yet significant count reduction in the classical monocyte subset as well as eosinophils. Testosterone‐independent immunoregulatory effects attributed to exercise included altered proportions of some monocyte, T‐ and B‐cell subsets, and reduced IL‐12, IL‐17, TNF‐α, MIP‐1β and sICAM‐1 in spite of interindividual variability. CONCLUSION: Overall, our findings indicate anti‐inflammatory effects of exercise training in IBM patients, whilst concomitant testosterone supplementation provides some additional changes. Further studies combining testosterone and exercise would be worthwhile in larger cohorts and longer testosterone administration periods. |
format | Online Article Text |
id | pubmed-9495304 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94953042022-09-30 Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial Coudert, Jerome D Slater, Nataliya Sooda, Anuradha Beer, Kelly Lim, Ee Mun Boyder, Conchita Zhang, Rui Mastaglia, Frank L Learmonth, Yvonne C Fairchild, Timothy J Yeap, Bu B Needham, Merrilee Clin Transl Immunology Original Articles OBJECTIVES: Sporadic Inclusion Body Myositis (IBM) is an inflammatory muscle disease affecting individuals over the age of 45, leading to progressive muscle wasting, disability and loss of independence. Histologically, IBM is characterised by immune changes including myofibres expressing major histocompatibility complex molecules and invaded by CD8(+) T cells and macrophages, and by degenerative changes including protein aggregates organised in inclusion bodies, rimmed vacuoles and mitochondrial abnormalities. There is currently no cure, and regular exercise is currently the only recognised treatment effective at limiting muscle weakening, atrophy and loss of function. Testosterone exerts anti‐inflammatory effects, inhibiting effector T‐cell differentiation and pro‐inflammatory cytokine production. METHODS: We conducted a double‐blind, placebo‐controlled, cross‐over trial in men with IBM, to assess whether a personalised progressive exercise training combined with application of testosterone, reduced the inflammatory immune response associated with this disease over and above exercise alone. To assess intervention efficacy, we immunophenotyped blood immune cells by flow cytometry, and measured serum cytokines and chemokines by Luminex immunoassay. RESULTS: Testosterone supplementation resulted in modest yet significant count reduction in the classical monocyte subset as well as eosinophils. Testosterone‐independent immunoregulatory effects attributed to exercise included altered proportions of some monocyte, T‐ and B‐cell subsets, and reduced IL‐12, IL‐17, TNF‐α, MIP‐1β and sICAM‐1 in spite of interindividual variability. CONCLUSION: Overall, our findings indicate anti‐inflammatory effects of exercise training in IBM patients, whilst concomitant testosterone supplementation provides some additional changes. Further studies combining testosterone and exercise would be worthwhile in larger cohorts and longer testosterone administration periods. John Wiley and Sons Inc. 2022-09-22 /pmc/articles/PMC9495304/ /pubmed/36188123 http://dx.doi.org/10.1002/cti2.1416 Text en © 2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Coudert, Jerome D Slater, Nataliya Sooda, Anuradha Beer, Kelly Lim, Ee Mun Boyder, Conchita Zhang, Rui Mastaglia, Frank L Learmonth, Yvonne C Fairchild, Timothy J Yeap, Bu B Needham, Merrilee Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial |
title | Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial |
title_full | Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial |
title_fullStr | Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial |
title_full_unstemmed | Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial |
title_short | Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial |
title_sort | immunoregulatory effects of testosterone supplementation combined with exercise training in men with inclusion body myositis: a double‐blind, placebo‐controlled, cross‐over trial |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495304/ https://www.ncbi.nlm.nih.gov/pubmed/36188123 http://dx.doi.org/10.1002/cti2.1416 |
work_keys_str_mv | AT coudertjeromed immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial AT slaternataliya immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial AT soodaanuradha immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial AT beerkelly immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial AT limeemun immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial AT boyderconchita immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial AT zhangrui immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial AT mastagliafrankl immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial AT learmonthyvonnec immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial AT fairchildtimothyj immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial AT yeapbub immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial AT needhammerrilee immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial |